Triumvira Immunologics

Loading...

About Triumvira Immunologics

Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current cancer treatments, including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. Our proprietary T cell Antigen Coupler (TAC) technology recruits the entire natural T cell receptor and is independent of the major histocompatibility complex (MHC), allowing for the development of better therapies for a broader range of patients with solid or liquid malignancies and also with diseases other than cancer.

Facts about Triumvira Immunologics
  • Founding: 2015
  • Focus : Manufacturer
  • Employees: 11-50
  • Industry : Biotechnology, Pharma

Here you will find Triumvira Immunologics, Inc.